This inventor holds 3 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Invitae Corporation, Laboratory Corporation of America Holdings. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022-2024
Title: Jason A Reuter: Innovator in Genetic and Genomic Testing
Introduction
Jason A Reuter is a notable inventor based in Palo Alto, CA (US). He has made significant contributions to the field of genetic and genomic testing through his innovative patents. With a total of 3 patents, Reuter's work focuses on optimizing the interpretation of molecular variants.
Latest Patents
One of his latest patents is a molecular evidence platform designed for auditable, continuous optimization of variant interpretation in genetic and genomic testing and analysis. This patent discloses system, method, and computer program product embodiments aimed at enhancing the determination of the phenotypic impact of molecular variants identified in tests, samples, or reports. The platform regularly incorporates, updates, monitors, validates, selects, and audits the best-performing evidence models for interpreting molecular variants across various evidence classes.
Career Highlights
Throughout his career, Jason A Reuter has worked with prominent companies in the biotechnology sector, including Invitae Corporation and Laboratory Corporation of America Holdings. His experience in these organizations has allowed him to develop and refine his innovative ideas in genetic testing.
Collaborations
Some of his notable coworkers include Alexandre Colavin and Carlos L Araya. Their collaboration has contributed to the advancement of research and development in the field.
Conclusion
Jason A Reuter is a distinguished inventor whose work in genetic and genomic testing continues to impact the industry. His innovative patents and collaborations highlight his commitment to advancing the understanding of molecular variants.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile